Moreover, Pang et al. found that, in these animals, increased fat mass and systemic inflammation occurred after the development of altered glucose homeostasis, which was not accompanied by decreased insulin sensitivity [42], thus suggesting that galectin-3 modulates β-cell function, irrespective of obesity-related inflammation. The gene discussed is LGALS3; the disease is obesity disorder.